United Therapeutics
UTHR
UTHR
470 hedge funds and large institutions have $10.3B invested in United Therapeutics in 2022 Q2 according to their latest regulatory filings, with 94 funds opening new positions, 148 increasing their positions, 159 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 425 → 470 (+45)
0.54% less ownership
Funds ownership: 97.51% → 96.97% (-0.54%)
7% less repeat investments, than reductions
Existing positions increased: 148 | Existing positions reduced: 159
Holders
470
Holding in Top 10
24
Calls
$79.5M
Puts
$30M
Top Buyers
| 1 | +$102M | |
| 2 | +$42.2M | |
| 3 | +$39.9M | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$32.6M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$31M |
Top Sellers
| 1 | -$52.2M | |
| 2 | -$41.8M | |
| 3 | -$41M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$38.1M |
| 5 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$34.1M |